ImmunityBio (IBRX) Shares Issued (2016 - 2024)
Historic Shares Issued for ImmunityBio (IBRX) over the last 11 years, with Q3 2024 value amounting to $15.6 million.
- ImmunityBio's Shares Issued changed N/A to $15.6 million in Q3 2024 from the same period last year, while for Jun 2025 it was $15.6 million, marking a year-over-year decrease of 7664.92%. This contributed to the annual value of $73.3 million for FY2024, which is N/A changed from last year.
- ImmunityBio's Shares Issued amounted to $15.6 million in Q3 2024.
- ImmunityBio's Shares Issued's 5-year high stood at $93.9 million during Q2 2021, with a 5-year trough of -$131.5 million in Q4 2021.
- In the last 5 years, ImmunityBio's Shares Issued had a median value of $600000.0 in 2020 and averaged $6.8 million.
- Per our database at Business Quant, ImmunityBio's Shares Issued tumbled by 9339.88% in 2022 and then skyrocketed by 4197619.05% in 2024.
- Over the past 5 years, ImmunityBio's Shares Issued (Quarter) stood at $400000.0 in 2020, then plummeted by 32971.75% to -$131.5 million in 2021, then surged by 99.94% to -$74000.0 in 2022, then tumbled by 70.27% to -$126000.0 in 2023, then surged by 12494.44% to $15.6 million in 2024.
- Its Shares Issued was $15.6 million in Q3 2024, compared to $52.8 million in Q2 2024 and $14.1 million in Q1 2024.